Coherus BioSciences, Inc. (Nasdaq: CHRS) announced that it has received a favorable decision from the Patent Trial and Appeal Board ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE